Blog
What Is Glucagon-Like Peptide-1? A Simple Guide
If you have searched what is glucagon-like peptide-1, you may have seen the term GLP-1 in discussions about blood sugar, diabetes, appetite, and weight management. GLP-1 stands for glucagon-like peptide-1. It is a naturally occurring hormone that plays an important role in how the body responds to food.
GLP-1 is mainly released by specialized cells in the intestine after you eat. It helps the body manage blood glucose by increasing insulin release when glucose levels are elevated. It can also reduce glucagon release, slow the movement of food from the stomach into the small intestine, and contribute to feelings of fullness.
Understanding what is glucagon-like peptide-1 is especially useful because medicines that activate the GLP-1 receptor are now widely used for certain people with type 2 diabetes and for weight management. These medicines are designed to produce effects that are similar to some actions of natural GLP-1, but they are not identical to the short-lived hormone made by the body.
This guide explains what is glucagon-like peptide-1, where it comes from, how it works, its effects on blood sugar and appetite, how GLP-1 receptor agonists work, and what to know about their safety.
What Is Glucagon-Like Peptide-1?
GLP-1 Definition
So, what is glucagon-like peptide-1 in simple terms?
Glucagon-like peptide-1, commonly called GLP-1, is a peptide hormone involved in blood glucose regulation, digestion, and appetite control. It belongs to a group of hormones called incretins.
Incretins are hormones released by the digestive system in response to food. They help coordinate what happens after a meal. GLP-1 is one of the best-known incretin hormones.
GLP-1 does not work alone. A complex system involving the pancreas, liver, digestive tract, brain, muscles, and other tissues controls blood glucose. Hormones such as insulin and glucagon also play major roles.
The term “glucagon-like” can be confusing. GLP-1 and glucagon are related at the molecular level, but they have different functions. In many situations, glucagon raises blood glucose, while GLP-1 helps promote glucose-dependent insulin release and can suppress glucagon when glucose is elevated.
Where Is GLP-1 Produced?
GLP-1 is produced mainly by specialized enteroendocrine cells in the intestine. These cells detect nutrients and release hormones that help the body respond to food.
The intestine is therefore an important source of GLP-1. After food enters the digestive system, nutrients stimulate the release of GLP-1 into the bloodstream.
GLP-1 can then interact with GLP-1 receptors in different parts of the body.
Research has also shown that GLP-1-related signaling involves the gut and brain. The digestive system communicates with the brain through hormonal and nerve pathways, helping regulate food intake and satiety.
This explains why what is glucagon-like peptide-1 is not simply a question about blood sugar. GLP-1 is part of a larger communication system between the digestive system, pancreas, and brain.
When Is GLP-1 Released?
GLP-1 is released in response to food intake.
After you eat, nutrients in the digestive tract help stimulate hormone-producing intestinal cells. GLP-1 is then released and contributes to the body’s response to the meal.
One important effect is helping the pancreas release insulin when blood glucose is elevated. What is a peptide? GLP-1 also affects digestion and appetite.
Natural GLP-1 does not remain active in the bloodstream for a long time. It is rapidly broken down, which limits how long its effects last. This short duration was one reason researchers developed longer-lasting medicines that activate the GLP-1 receptor.
How Does GLP-1 Work?
GLP-1 and Blood Sugar
A major part of understanding what is glucagon-like peptide-1 is understanding its role in blood glucose control.
When you eat carbohydrates, they are digested into glucose and other simple sugars. Glucose enters the bloodstream, and the body needs to keep blood glucose within a healthy range.
GLP-1 helps coordinate this response.
When blood glucose is elevated, GLP-1 can increase insulin secretion from pancreatic beta cells. Insulin helps move glucose from the bloodstream into cells and tissues where it can be used or stored.
GLP-1 also influences glucagon secretion. This can help limit unnecessary glucose release from the liver when blood glucose is already elevated.
The overall effect is to support better control of blood glucose after meals.
GLP-1 and Insulin
Insulin and GLP-1 have an important relationship.
Insulin is a hormone produced by pancreatic beta cells. Its primary role is to help lower blood glucose by promoting glucose uptake and storage.
GLP-1 does not replace insulin. Instead, natural GLP-1 helps stimulate insulin release when appropriate, particularly when blood glucose is elevated.
This glucose-dependent action is an important feature of GLP-1 biology.
For people with type 2 diabetes, GLP-1 receptor agonist medicines can improve blood glucose control by activating the same receptor pathway used by natural GLP-1. However, these medicines do not simply act as another form of insulin. NIDDK specifically notes that GLP-1 medicines are not substitutes for insulin.
GLP-1 and Glucagon
Glucagon and GLP-1 have different roles in glucose regulation.
Glucagon is produced by pancreatic alpha cells. When blood glucose becomes too low, glucagon signals the liver to release glucose into the bloodstream.
GLP-1 can reduce glucagon secretion when blood glucose is elevated.
This relationship helps explain the name “glucagon-like peptide.” Although GLP-1 is structurally related to glucagon, the two hormones have different physiological roles.
It is useful to think of insulin and glucagon as two major regulators that often work in opposite directions. GLP-1 is part of the system that helps the body respond to food and coordinate insulin and glucagon activity.
GLP-1 and Digestion
GLP-1 also affects the digestive system.
One important effect is slowing gastric emptying. In simple terms, food can move more slowly from the stomach into the small intestine.
This can slow the rise in blood glucose after a meal and may also contribute to feelings of fullness.
The effect is not the same as stopping digestion. Instead, it changes the timing of how quickly stomach contents move into the intestine.
This digestive effect is one reason GLP-1 receptor agonist medicines can cause gastrointestinal symptoms, particularly when treatment is started or the dose is increased.
What Does GLP-1 Do in the Body?
Supports Blood Glucose Regulation
GLP-1 is an important part of the body’s response to eating.
Its effects include stimulating insulin release when glucose levels are elevated and helping reduce glucagon activity under appropriate conditions.
Together, these effects can help control blood glucose after meals.
However, blood glucose regulation involves many systems. GLP-1 is one piece of that larger process rather than the body’s only glucose-regulating hormone.
This distinction matters when considering what is glucagon-like peptide-1. GLP-1 contributes to glucose regulation, but it does not independently control blood sugar.
Slows Gastric Emptying
Another important action of GLP-1 is its effect on gastric emptying.
Gastric emptying refers to the movement of food from the stomach into the small intestine.
When this process slows, nutrients may enter the small intestine at a slower pace. This can influence the speed at which glucose enters the bloodstream.
GLP-1 receptor agonist medicines can also slow gastric emptying, although the degree and duration of this effect can vary between medicines and individuals.
Influences Appetite and Fullness
GLP-1 also affects appetite.
GLP-1 signaling is involved in communication between the digestive system and the brain. Activation of GLP-1 receptors can influence areas involved in appetite, food intake, and feelings of fullness.
This is one reason GLP-1 receptor agonists can help some people eat less and lose weight when they are used as part of an appropriate medical treatment plan.
NIDDK notes that GLP-1-based medicines can target areas of the brain involved in appetite and food intake.
Other Functions of GLP-1
Researchers continue to study the broader effects of GLP-1 signaling.
GLP-1 is involved in communication between the gut, pancreas, and brain. Its effects are linked to nutrient sensing, insulin secretion, gastric emptying, appetite, and glucose regulation.
There is also ongoing research into how GLP-1-based medicines may affect conditions beyond their original uses.
However, research findings should be separated from established clinical uses. A biological effect observed in a laboratory or clinical study does not automatically mean that a GLP-1 medicine is approved or appropriate for every condition.
GLP-1 and Weight Management
How GLP-1 Affects Appetite
One of the reasons GLP-1 has received so much attention is its effect on appetite.
GLP-1 signaling can influence brain pathways involved in hunger and satiety. When these pathways are activated by GLP-1 receptor agonist medicines, some people experience less hunger and greater feelings of fullness.
This can make it easier for some people to reduce food intake.
However, appetite is influenced by many factors. Sleep, stress, food environment, activity, medications, medical conditions, and other hormones can all affect hunger and eating behavior.
GLP-1 is therefore one part of a much larger appetite-control system.
GLP-1 and Food Intake
Because GLP-1 can affect hunger, fullness, and gastric emptying, GLP-1 receptor agonist medicines may reduce food intake in some people.
The effect is not simply about willpower. Appetite is regulated by biological systems that influence how strongly a person feels hunger and how satisfied they feel after eating.
For people with obesity or overweight combined with certain health conditions, prescription weight-management medicines may be considered as part of a broader treatment plan. NIDDK notes that these medicines can be used alongside lifestyle approaches for appropriate patients.
The Difference Between Natural GLP-1 and GLP-1 Medicines
Natural GLP-1 is a hormone produced by the body. It is released after food intake and is broken down quickly.
GLP-1 receptor agonist medicines are designed to activate the GLP-1 receptor for much longer than natural GLP-1.
This difference is crucial.
If natural GLP-1 stayed active for only a few minutes, it would not be practical as a conventional long-lasting medicine. Researchers therefore developed molecules that could produce similar receptor effects while remaining active for longer periods.
So, what is glucagon-like peptide-1 compared with a GLP-1 drug? Natural GLP-1 is the body’s own hormone. A GLP-1 receptor agonist is a medicine designed to mimic or activate important effects of that hormone.
What Are GLP-1 Receptor Agonists?
How GLP-1 Medications Work
GLP-1 receptor agonists are medicines that activate the GLP-1 receptor.
They are designed to produce several effects associated with natural GLP-1 signaling. Depending on the medicine, these can include increased glucose-dependent insulin release, reduced glucagon activity, slower gastric emptying, and reduced appetite.
Some medicines in this class are used to treat type 2 diabetes. Certain GLP-1 receptor agonists are also approved for chronic weight management in appropriate patients.
Examples include liraglutide and semaglutide. The exact approved uses, doses, age groups, and formulations vary by product and country.
There are also newer medicines that activate more than one metabolic hormone pathway. For example, tirzepatide activates both GIP and GLP-1 receptors, so it is not a pure GLP-1 receptor agonist.
Common Medical Uses
GLP-1 receptor agonists are used in medicine for specific approved indications.
One major use is the management of type 2 diabetes. These medicines can help lower blood glucose and, for some people, support weight reduction.
Some medicines in this group are also approved for chronic weight management in people who meet specific medical criteria.
Current clinical guidance also recognizes roles for GLP-1 receptor agonists in certain people with type 2 diabetes and related health conditions. For example, NIDDK’s summary of 2025 diabetes guidance describes recommendations involving GLP-1 receptor agonists for certain people with type 2 diabetes and chronic kidney disease.
The appropriate medicine depends on the individual’s health, treatment goals, other medicines, medical history, and the specific regulatory approvals that apply.
How GLP-1 Receptor Agonists Differ From Natural GLP-1
Natural GLP-1 is quickly broken down in the bloodstream.
GLP-1 receptor agonists are engineered to remain active much longer. Some are taken daily, while others are administered weekly, depending on the medicine.
The longer activity allows these medicines to produce sustained GLP-1 receptor stimulation.
This is one of the most important differences when explaining what is glucagon-like peptide-1 and why it is different from a GLP-1 medication.
A natural hormone and a medicine that activates its receptor are related, but they are not necessarily chemically identical.
Potential Benefits of GLP-1
Blood Sugar Management
GLP-1 receptor agonists can help lower blood glucose in people with type 2 diabetes.
They do this through several pathways, including increasing insulin secretion when glucose is elevated and reducing inappropriate glucagon activity.
They may also slow gastric emptying, which can affect the rate at which glucose enters the bloodstream after eating.
The exact response differs from person to person.
Appetite Regulation
GLP-1 receptor activation can influence appetite and satiety.
Some people taking GLP-1 receptor agonists report feeling less hungry or becoming full sooner. This can reduce food intake and contribute to weight loss.
The effect is partly related to signaling in the brain and partly related to changes in digestion and gastric emptying.
Weight Management
Some GLP-1 receptor agonists are approved for chronic weight management in people who meet specific criteria.
Weight loss can also help improve some obesity-related health risks.
However, these medicines are not appropriate for everyone, and treatment decisions should be individualized.
NIDDK emphasizes that weight-management medications may help some people but are not right for everyone.
It is also important to understand that treatment may need to continue over time. Weight can return after stopping medication, and long-term treatment decisions should be discussed with a healthcare professional.
Areas of Ongoing Research
Researchers continue to investigate GLP-1 signaling and GLP-1-based medicines.
Areas of research include metabolic disease, cardiovascular health, kidney health, liver disease, and the biology of appetite and energy regulation.
Some research findings are promising, but research is not the same as an approved medical indication.
For example, a study may show that a medicine changes a biological marker without proving that it should be used routinely to treat a particular disease.
When evaluating claims about what is glucagon-like peptide-1, it is important to distinguish established clinical uses from areas that are still being investigated.
GLP-1 Side Effects and Safety
Common Side Effects of GLP-1 Medicines
GLP-1 receptor agonists can cause side effects.
Gastrointestinal symptoms are among the most common concerns. These may include:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Abdominal discomfort
- Reduced appetite
The severity varies between people.
Some symptoms may be more noticeable when treatment begins or when the dose increases.
FDA reports have also highlighted gastrointestinal symptoms among adverse events associated with dosing problems involving certain compounded GLP-1 products.
Not every symptom experienced while taking a medicine is necessarily caused by the medicine. Other health conditions, foods, other medications, or unrelated factors may contribute.
Important Safety Considerations
GLP-1 medicines have specific warnings and precautions.
For example, certain GLP-1 medicines should not be used by people with a personal or family history of medullary thyroid carcinoma or by people with multiple endocrine neoplasia syndrome type 2, according to prescribing information summarized by NIDDK for certain weight-management medicines.
The relevant warnings differ by product.
There are also concerns about incorrect dosing with some compounded products. FDA has reported adverse events associated with dosing errors involving compounded semaglutide and tirzepatide, including cases requiring hospitalization.
For this reason, consumers should be especially cautious about products purchased from unofficial websites or sources that do not provide reliable information about manufacturing, ingredients, dosage, or medical supervision.
Why Medical Guidance Matters
Prescription GLP-1 medicines affect important biological systems.
Before using one, a healthcare professional can review your medical history, current medicines, health conditions, treatment goals, and potential risks.
This is especially important if you have diabetes, gastrointestinal disease, kidney problems, a history of certain endocrine conditions, or take medicines that can affect blood glucose.
Medical guidance also matters when changing or stopping treatment.
A prescription medicine should be used according to its approved instructions and the plan provided by your healthcare professional.
GLP-1 vs. Other Metabolic Hormones
GLP-1 vs. Glucagon
GLP-1 and glucagon are different hormones with different primary roles.
Glucagon is produced by pancreatic alpha cells. It helps raise blood glucose, especially when glucose levels are low, by signaling the liver to release glucose.
GLP-1 is mainly produced by intestinal cells after food intake. It helps support insulin release when glucose is elevated and can reduce glucagon activity in that setting.
Although their names sound similar, their effects are not simply opposites in every situation.
The relationship between these hormones is part of the body’s larger glucose-regulation system.
GLP-1 vs. Insulin
Insulin and GLP-1 are also different.
Insulin is a hormone produced by pancreatic beta cells. It directly helps regulate glucose by promoting glucose uptake and storage.
GLP-1 is an incretin hormone that helps stimulate insulin secretion in response to elevated glucose.
This means GLP-1 can influence insulin release, but GLP-1 is not insulin.
This distinction is especially important for people with diabetes. GLP-1 receptor agonists may improve glucose control, but they are not substitutes for insulin in people who need insulin therapy.
How These Hormones Work Together
Blood glucose regulation depends on several hormones working together.
After a meal, glucose rises and the body increases insulin activity. GLP-1 contributes to this response by helping stimulate insulin secretion.
When blood glucose falls, glucagon becomes more important because it helps the liver release glucose.
The nervous system, digestive tract, pancreas, liver, muscles, and fat tissue also contribute to maintaining glucose balance.
This coordinated system is why what is glucagon-like peptide-1 should be understood as part of a broader metabolic network rather than as an isolated hormone.
FAQ
What is glucagon-like peptide-1?
What is glucagon-like peptide-1? It is a naturally occurring peptide hormone, commonly called GLP-1, that is mainly released by specialized cells in the intestine after eating.
It helps the body respond to food by supporting glucose-dependent insulin release, influencing glucagon secretion, slowing gastric emptying, and contributing to appetite and fullness signals.
Natural GLP-1 is short-lived in the bloodstream, which is why longer-acting GLP-1 receptor agonist medicines were developed.
What does GLP-1 do?
GLP-1 has several functions.
It helps stimulate insulin release when blood glucose is elevated, can reduce glucagon secretion in that setting, slows gastric emptying, and contributes to appetite and satiety regulation.
These effects help the body coordinate its response to food.
The exact effect depends on the biological setting and whether we are discussing natural GLP-1 or a medication that activates the GLP-1 receptor.
Where is GLP-1 produced?
GLP-1 is mainly produced by specialized hormone-producing cells in the intestine.
These cells respond to nutrients from food and release GLP-1 as part of the body’s post-meal response.
GLP-1 then acts through receptors in different tissues, including the pancreas and areas involved in appetite regulation.
Is GLP-1 a hormone?
Yes. GLP-1 is a peptide hormone and an incretin hormone.
An incretin is a hormone released by the digestive system that helps regulate the body’s response to food.
GLP-1 is one of the major incretin hormones. Another important incretin is glucose-dependent insulinotropic polypeptide, or GIP.
How does GLP-1 affect appetite?
GLP-1 signaling can affect brain pathways involved in hunger, food intake, and satiety.
GLP-1 receptor agonist medicines can make some people feel less hungry and fuller after eating. This can lead to lower food intake and may contribute to weight loss.
Appetite is complex, though, and GLP-1 is only one part of the system that controls eating behavior.
What are GLP-1 receptor agonists?
GLP-1 receptor agonists are medicines that activate the receptor used by natural GLP-1.
They are used for certain people with type 2 diabetes and, depending on the specific product and regulatory approval, for chronic weight management.
Examples include liraglutide and semaglutide. Different products have different approved uses, doses, formulations, and safety information.
Is natural GLP-1 the same as semaglutide?
Natural GLP-1 is a hormone produced by the body and broken down quickly. Semaglutide is a medicine designed to activate the GLP-1 receptor for much longer.
The two are therefore related through their receptor activity, but they are not the same molecule.
Does GLP-1 cause weight loss naturally?
Natural GLP-1 contributes to appetite and satiety regulation, but it is only one part of the body’s complex system for controlling food intake and body weight.
Natural GLP-1 is also rapidly broken down, so its effects are relatively brief.
Longer-acting GLP-1 receptor agonists can produce more sustained receptor activation and may cause significant weight loss in appropriate patients.
Can everyone take GLP-1 medicines?
GLP-1 medicines are prescription treatments with specific approved uses, contraindications, warnings, and potential side effects.
Whether a particular medicine is appropriate depends on factors such as medical history, current medications, health conditions, and treatment goals.
A healthcare professional can determine whether a GLP-1-based medicine is suitable.
Are GLP-1 medicines the same as insulin?
Insulin is a hormone that directly helps lower blood glucose. GLP-1 receptor agonists work through the GLP-1 receptor and can stimulate insulin release when glucose is elevated.
Some people may need both types of medicine, depending on their condition and treatment plan.
GLP-1 medicines should not be considered automatic replacements for insulin.
Conclusion
So, what is glucagon-like peptide-1? GLP-1 is a naturally occurring peptide hormone that helps the body respond to food. It is mainly released by specialized cells in the intestine after eating.
GLP-1 plays several important roles. It helps stimulate insulin release when blood glucose is elevated, influences glucagon secretion, slows gastric emptying, and contributes to appetite and fullness signals.
These effects make GLP-1 an important part of normal glucose and energy regulation.
The growing interest in what is glucagon-like peptide-1 is also linked to GLP-1 receptor agonist medicines. These medicines activate the same receptor pathway as natural GLP-1 but are designed to last much longer. They are used for specific medical purposes, including type 2 diabetes and, for certain products and patients, chronic weight management.
It is important to distinguish the natural hormone from GLP-1 medications. Natural GLP-1 is produced by the body and quickly broken down. GLP-1 receptor agonists are medicines designed to produce longer-lasting effects.
In simple terms, what is glucagon-like peptide-1 can be answered in one sentence: GLP-1 is a gut-derived peptide hormone that helps regulate blood sugar, digestion, appetite, and the body’s response to food.
Because GLP-1 medicines can have important effects and side effects, they should be used only for appropriate medical purposes and with proper professional guidance.
